Zacks Investment Research upgraded shares of AGEAS/S (OTCMKTS:AGESY) from a sell rating to a hold rating in a research note released on Thursday.

According to Zacks, “Ageas, formerly known as Fortis, is an international insurance company. The Company has chosen to concentrate its business activities in Europe and Asia. Ageas offers international insurance services such as life and non-life, disability, and medical to individuals and groups. The Company also has subsidiaries in France, Germany, Turkey, Ukraine and Hong Kong. Ageas operates partnerships in Luxembourg, Italy, Portugal, China, Malaysia, India and Thailand. “

Separately, ValuEngine downgraded shares of AGEAS/S from a hold rating to a sell rating in a report on Thursday, December 6th.

AGESY traded up $0.10 on Thursday, reaching $45.43. 10,465 shares of the stock were exchanged, compared to its average volume of 13,191. AGEAS/S has a fifty-two week low of $43.43 and a fifty-two week high of $55.54. The company has a debt-to-equity ratio of 0.20, a quick ratio of 0.05 and a current ratio of 0.05. The stock has a market cap of $9.35 billion, a P/E ratio of 13.02, a P/E/G ratio of 1.35 and a beta of 0.76.

AGEAS/S (OTCMKTS:AGESY) last issued its earnings results on Wednesday, November 14th. The financial services provider reported $1.26 earnings per share for the quarter. AGEAS/S had a net margin of 7.31% and a return on equity of 8.64%. The firm had revenue of $3.48 billion during the quarter. Analysts predict that AGEAS/S will post 4.74 EPS for the current fiscal year.

About AGEAS/S

ageas SA/NV, together with its subsidiaries, engages in insurance business in Europe and Asia. The company primarily offers property, casualty, and life insurance products, as well as pension products; and reinsurance products. Its life insurance products include risks related to the life and death of individuals; and non-life insurance products comprise accident and health, motor, fire and other damage to property, and other insurance products.

Featured Story: The benefits and drawbacks of dollar cost averaging

Get a free copy of the Zacks research report on AGEAS/S (AGESY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for AGEAS/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGEAS/S and related companies with MarketBeat.com's FREE daily email newsletter.